Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Bosanac, P
Mancuso, SG
and
Castle, D
2013.
Anxiety symptoms in psychotic disorders.
Clinical Schizophrenia & Related Psychoses,
p.
1.
Whiteford, Harvey A.
Ferrari, Alize J.
Baxter, Amanda J.
Charlson, Fiona J.
and
Degenhardt, Louisa
2013.
How did we arrive at burden of disease estimates for mental and illicit drug use disorders in the Global Burden of Disease Study 2010?.
Current Opinion in Psychiatry,
Vol. 26,
Issue. 4,
p.
376.
Baxter, Amanda J.
Patton, George
Scott, Kate M.
Degenhardt, Louisa
Whiteford, Harvey A.
and
Bhutta, Zulfiqar A.
2013.
Global Epidemiology of Mental Disorders: What Are We Missing?.
PLoS ONE,
Vol. 8,
Issue. 6,
p.
e65514.
Malan-Müller, Stefanie
Hemmings, Sîan Megan Joanna
and
Seedat, Soraya
2013.
Big Effects of Small RNAs: A Review of MicroRNAs in Anxiety.
Molecular Neurobiology,
Vol. 47,
Issue. 2,
p.
726.
Whiteford, Harvey A
Degenhardt, Louisa
Rehm, Jürgen
Baxter, Amanda J
Ferrari, Alize J
Erskine, Holly E
Charlson, Fiona J
Norman, Rosana E
Flaxman, Abraham D
Johns, Nicole
Burstein, Roy
Murray, Christopher JL
and
Vos, Theo
2013.
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.
The Lancet,
Vol. 382,
Issue. 9904,
p.
1575.
Salum, Giovanni Abrahao
DeSousa, Diogo Araujo
Rosario, Maria Conceicao do
Pine, Daniel Samuel
and
Manfro, Gisele Gus
2013.
Pediatric anxiety disorders: from neuroscience to evidence-based clinical practice.
Revista Brasileira de Psiquiatria,
Vol. 35,
Issue. suppl 1,
p.
S03.
Schulte-van Maaren, Yvonne W.M.
Giltay, Erik J.
van Hemert, Albert M.
Zitman, Frans G.
de Waal, Margot W.M.
and
Carlier, Ingrid V.E.
2013.
Reference values for anxiety questionnaires: The Leiden Routine Outcome Monitoring Study.
Journal of Affective Disorders,
Vol. 150,
Issue. 3,
p.
1008.
Lewis, Florence
Merckaert, Isabelle
Liénard, Aurore
Libert, Yves
Etienne, Anne-Marie
Reynaert, Christine
Slachmuylder, Jean-Louis
Scalliet, Pierre
Paul, Van Houtte
Coucke, Philippe
Salamon, Emile
and
Razavi, Darius
2014.
Anxiety and its time courses during radiotherapy for non-metastatic breast cancer: A longitudinal study.
Radiotherapy and Oncology,
Vol. 111,
Issue. 2,
p.
276.
Baxter, Amanda J.
Vos, Theo
Scott, Kate M.
Norman, Rosana E.
Flaxman, Abraham D.
Blore, Jed
and
Whiteford, Harvey A.
2014.
The regional distribution of anxiety disorders: implications for the Global Burden of Disease Study, 2010.
International Journal of Methods in Psychiatric Research,
Vol. 23,
Issue. 4,
p.
422.
Steel, Zachary
Marnane, Claire
Iranpour, Changiz
Chey, Tien
Jackson, John W
Patel, Vikram
and
Silove, Derrick
2014.
The global prevalence of common mental disorders: a systematic review and meta-analysis 1980–2013.
International Journal of Epidemiology,
Vol. 43,
Issue. 2,
p.
476.
Shal'nova, S. A.
Evstifeeva, S. E
Deev, A. D.
Artamonova, G. V.
Gatagonova, T. M.
Dupliakov, D. V.
Efanov, A. Iu.
Zhernakova, Iu. V.
Konradi, A. O.
Libis, R. A.
Minakov, É. V.
Nedogoda, S. V.
Oshchepkova, E. V.
Romanchuk, S. V.
Rotar', O. P.
Trubacheva, I. A.
Shliakhto, E. V.
and
Boĭtsov, S. A.
2014.
The prevalence of anxiety and depression in different regions of the Russian Federation and its association with sociodemographic factors (according to the data of the ESSE-RF study).
Terapevticheskii arkhiv,
Vol. 86,
Issue. 12,
p.
53.
Menendez, Mariano E.
Neuhaus, Valentin
Bot, Arjan G. J.
Ring, David
and
Cha, Thomas D.
2014.
Psychiatric Disorders and Major Spine Surgery.
Spine,
Vol. 39,
Issue. 2,
p.
E111.
Schott, Amanda L.
and
Zimmerberg, Betty
2014.
Effects of Neurokinin-1 Receptor Inhibition on Anxiety Behavior in Neonatal Rats Selectively Bred for an Infantile Affective Trait.
Pharmacology & Pharmacy,
Vol. 05,
Issue. 09,
p.
859.
Baxter, Amanda J.
Scott, Kate M.
Ferrari, Alize J.
Norman, Rosana E.
Vos, Theo
and
Whiteford, Harvey A.
2014.
CHALLENGING THE MYTH OF AN “EPIDEMIC” OF COMMON MENTAL DISORDERS: TRENDS IN THE GLOBAL PREVALENCE OF ANXIETY AND DEPRESSION BETWEEN 1990 AND 2010.
Depression and Anxiety,
Vol. 31,
Issue. 6,
p.
506.
Kale, Pravin Popatrao
and
Addepalli, Veeranjaneyulu
2014.
Enhancement of Anxiolytic Effect of Duloxetine or Bupropion by Caffeine in Mice.
Journal of Caffeine Research,
Vol. 4,
Issue. 3,
p.
69.
Willis, Brian
and
Jones, Claire
2014.
Recognising and accepting ‘heightened awareness’: Supporting secondary school students with anxiety barriers using cognitive-behavioural therapy (CBT) approaches.
DECP Debate,
Vol. 1,
Issue. 152,
p.
23.
Altis, Kaylan L.
Elwood, Lisa S.
and
Olatunji, Bunmi O.
2014.
Ethical Issues in Behavioral Neuroscience.
Vol. 19,
Issue. ,
p.
265.
Ferrari, Alize J.
Norman, Rosana E.
Freedman, Greg
Baxter, Amanda J.
Pirkis, Jane E.
Harris, Meredith G.
Page, Andrew
Carnahan, Emily
Degenhardt, Louisa
Vos, Theo
Whiteford, Harvey A.
and
Baune, Bernhard T.
2014.
The Burden Attributable to Mental and Substance Use Disorders as Risk Factors for Suicide: Findings from the Global Burden of Disease Study 2010.
PLoS ONE,
Vol. 9,
Issue. 4,
p.
e91936.
Lau, Winnie Yu-Pow
Gau, Susan Shur-Fen
Chiu, Yen-Nan
and
Wu, Yu-Yu
2014.
Autistic Traits in Couple Dyads as a Predictor of Anxiety Spectrum Symptoms.
Journal of Autism and Developmental Disorders,
Vol. 44,
Issue. 11,
p.
2949.
Brühl, Annette Beatrix
Delsignore, Aba
Komossa, Katja
and
Weidt, Steffi
2014.
Neuroimaging in social anxiety disorder—A meta-analytic review resulting in a new neurofunctional model.
Neuroscience & Biobehavioral Reviews,
Vol. 47,
Issue. ,
p.
260.